BACKGROUND: To study the prevalence, predictors and outcome of late HIV diagnosis in the Icona cohort, according to the new European consensus definition of late diagnosis. METHODS: In this observational cohort study we investigated patients diagnosed with HIV over 3 months preceding enrolment who were defined as diagnosed late if they presented with AIDS or a CD4(+) T-cell count ≤ 350/mm³ (European consensus definition). We estimated the prevalence of late diagnosis, identified factors associated with being diagnosed late and looked at the prognostic value of the European consensus definition of late presentation to predict subsequent clinical progression (new AIDS events or death). RESULTS: In total, 1,438/2,276 patients (63%) were defined as diagnosed late using the new European Consensus definition. Of these, 387 (16%) were AIDS-presenters. Predictors of being diagnosed late were older age, non-Italian origin, high HIV RNA and unemployment (versus retirement). A total of 293 patients showed clinical progression (3 events/100 person-years of follow-up, 95% CI: 2.7-3.4). Presenting late was strongly associated with a >5-fold increased risk of disease progression. CONCLUSIONS: In our observational setting with free access to care, more than 60% of new HIV diagnoses occurred below the recommended threshold for initiating antiretroviral treatment. Presenting late for care was associated with a high risk of clinical progression.
BACKGROUND: To study the prevalence, predictors and outcome of late HIV diagnosis in the Icona cohort, according to the new European consensus definition of late diagnosis. METHODS: In this observational cohort study we investigated patients diagnosed with HIV over 3 months preceding enrolment who were defined as diagnosed late if they presented with AIDS or a CD4(+) T-cell count ≤ 350/mm³ (European consensus definition). We estimated the prevalence of late diagnosis, identified factors associated with being diagnosed late and looked at the prognostic value of the European consensus definition of late presentation to predict subsequent clinical progression (new AIDS events or death). RESULTS: In total, 1,438/2,276 patients (63%) were defined as diagnosed late using the new European Consensus definition. Of these, 387 (16%) were AIDS-presenters. Predictors of being diagnosed late were older age, non-Italian origin, high HIV RNA and unemployment (versus retirement). A total of 293 patients showed clinical progression (3 events/100 person-years of follow-up, 95% CI: 2.7-3.4). Presenting late was strongly associated with a >5-fold increased risk of disease progression. CONCLUSIONS: In our observational setting with free access to care, more than 60% of new HIV diagnoses occurred below the recommended threshold for initiating antiretroviral treatment. Presenting late for care was associated with a high risk of clinical progression.
Authors: Ethan Obie Romero-Severson; Cody Lee Petrie; Edward Ionides; Jan Albert; Thomas Leitner Journal: Int J Epidemiol Date: 2015-07-10 Impact factor: 7.196
Authors: J M Kittner; L von Bialy; J Wiltink; T Thomaidis; B Gospodinov; A Rieke; F Katz; T Discher; K Rath; B Claus; G Held; G Friese; B Schappert; M Schuchmann; P R Galle Journal: Infection Date: 2015-01-20 Impact factor: 3.553
Authors: Inês Dourado; Sarah MacCarthy; Carlos Lima; Maria Amélia Veras; Ligia Kerr; Ana Maria de Brito; Sofia Gruskin Journal: AIDS Care Date: 2014-07-17
Authors: G Sulis; I El Hamad; M Fabiani; S Rusconi; F Maggiolo; G Guaraldi; G Bozzi; C Bernardini; M Lichtner; C Stentarelli; L Carenzi; D Francisci; A Saracino; F Castelli Journal: Infection Date: 2014-06-29 Impact factor: 3.553
Authors: Stephen T Wright; Matthew G Law; David A Cooper; Phillip Keen; Ann McDonald; Melanie Middleton; Ian Woolley; Mark Kelly; Kathy Petoumenos Journal: J Int AIDS Soc Date: 2015-04-10 Impact factor: 5.396
Authors: Laura Camoni; Mariangela Raimondo; Vincenza Regine; Maria Cristina Salfa; Barbara Suligoi Journal: BMC Public Health Date: 2013-03-27 Impact factor: 3.295
Authors: A Cingolani; S Zona; E Girardi; A Cozzi-Lepri; L Monno; E Quiros Roldan; G Guaraldi; A Antinori; A D'Arminio Monforte; S Marcotullio Journal: HIV Med Date: 2015-05-11 Impact factor: 3.180